淋菌性尿道炎に対するBAY o 9867の細菌学的・臨床的検討
書誌事項
- タイトル別名
-
- CLINICAL STUDY ON BAY o 9867 IN GONOCOCCAL URETHRITIS
抄録
The purpose of this study was to determine the susceptibility of N. gonorrhoeae to BAY o 9867.<BR>The MIC of BAY o 9867 against 31 clinical strains of N.gonorrhoeae was examined and 28 strains showed MIC of ≤ 0.025μg/ml (90.3%) including 3 β-lactamase producing strains.<BR>BAY o 9867 was administered to 58 cases with gonorrhea without association of Chlamydia at initial dose of 200mg and following by 100mg three times a day for 3-6 days.<BR>The overall cure rate was 100%.3 patients with β-lactamase producing gonococcic infection were cured.<BR>Of 43 patients followed for 7 to 14 days after treatment, PGU was diagnosed in 12 patients (27.9%).<BR>Five (38.5%) of 13 patients, who were followed up, with Chlamydia positive cultures developed PGU, while 7 (23.3%) of 30 patients with Chlamydia negative cultures developed PGU.<BR>No remarkable side effects were observed except for headache in one case (1.7%).
収録刊行物
-
- CHEMOTHERAPY
-
CHEMOTHERAPY 33 (Supplement7), 621-631, 1985
公益社団法人 日本化学療法学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001206282554624
-
- NII論文ID
- 130004195198
-
- ISSN
- 18845894
- 00093165
-
- データソース種別
-
- JaLC
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可